PLD vs PPCB · P/E 27, rev $8.79B vs P/E 0.0, $3.9M cap
Prologis Inc (PLD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
PPCB does not have a complete income-statement cache yet.
PLD currently screens at market cap $100.23B and trailing P/E 26.9. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the PLD and PPCB stock pages for the full models.
Not investment advice.